packageTezacaftor

Tezacaftor

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tezacaftor is a CFTR corrector used, in combination with other cystic fibrosis drugs, to treat cystic fibrosis. It is an approved medicine used in combination therapy for eligible patients with cystic fibrosis, mainly in the United States and Europe.

Summary written by glm-5.3-flash from Wikidata Q27270940 and the WHO ATC classification; not checked by a person.

name:Tezacaftor
ATC codes:R07AX31, R07AX32, R07AX33
DrugBank:DB11712
PubChem CID:46199646
Wikidata:Q27270940
formula:C26H27F3N2O6
molar mass:520.504 g/mol (PubChem CID 46199646)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown